Insider Trading History of Lloyd-smith Malcolm


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lloyd-smith Malcolm since year 2005. The trader's CIK number is 1557146. At the time of the last reporting, Lloyd-smith Malcolm was the Chief Regulatory Officer of Neurocrine Biosciences Inc . (stock ticker symbol NBIX). See this page for all insider trading activities at Neurocrine Biosciences Inc .

Note that in the past Lloyd-Smith Malcolm also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lloyd-smith Malcolm since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-07 NBIX Neurocrine Biosciences Inc Sale 1,015 103.28 104,826
2020-02-10 NBIX Neurocrine Biosciences Inc Option Ex 28,969 57.24 1,658,185
2020-02-10 NBIX Neurocrine Biosciences Inc Sale 28,969 104.56 3,029,085
2020-02-05 NBIX Neurocrine Biosciences Inc Sale 1,948 103.05 200,735
2020-02-06 NBIX Neurocrine Biosciences Inc Sale 1,490 101.52 151,257
2019-10-14 NBIX Neurocrine Biosciences Inc Option Ex 9,956 15.45 153,820
2019-10-14 NBIX Neurocrine Biosciences Inc Sale 9,956 90.85 904,482
2019-02-06 NBIX Neurocrine Biosciences Inc Sale 920 83.58 76,893
2019-02-05 NBIX Neurocrine Biosciences Inc Sale 1,272 88.14 112,117
2018-11-06 NBIX Neurocrine Biosciences Inc Option Ex 5,700 15.45 88,065
2018-11-07 NBIX Neurocrine Biosciences Inc Option Ex 3,300 15.45 50,985
2018-11-06 NBIX Neurocrine Biosciences Inc Sale 5,700 110.02 627,096
2018-11-07 NBIX Neurocrine Biosciences Inc Sale 3,300 110.00 363,000
2018-02-05 NBIX Neurocrine Biosciences Inc Sale 960 83.19 79,862
2018-01-02 NBIX Neurocrine Biosciences Inc Option Ex 18,084 15.45 279,397
2018-01-02 NBIX Neurocrine Biosciences Inc Sale 18,084 77.52 1,401,817
2017-05-18 NBIX Neurocrine Biosciences Inc Option Ex 4,980 15.45 76,941
2017-05-19 NBIX Neurocrine Biosciences Inc Option Ex 4,980 15.45 76,941
2017-05-18 NBIX Neurocrine Biosciences Inc Sale 4,980 53.26 265,234
2017-05-19 NBIX Neurocrine Biosciences Inc Sale 4,980 54.00 268,920
2017-04-12 NBIX Neurocrine Biosciences Inc Sale 13,065 50.82 663,963
2017-02-07 NBIX Neurocrine Biosciences Inc Sale 116 44.61 5,174
2017-02-06 NBIX Neurocrine Biosciences Inc Sale 727 43.15 31,370
2016-09-01 NBIX Neurocrine Biosciences Inc Option Ex 9,000 15.45 139,050
2016-09-01 NBIX Neurocrine Biosciences Inc Sale 9,000 50.00 450,000
2013-07-22 CADX Cadence Pharmaceuticals Inc Option Ex 14,000 3.51 49,140
2013-07-22 CADX Cadence Pharmaceuticals Inc Sale 14,000 7.85 109,900
2013-06-10 CADX Cadence Pharmaceuticals Inc Sale 4,000 7.44 29,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lloyd-smith Malcolm (Chief Regulatory Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month